Short-course antidepressant therapy reduces discontinuation syndrome while maintaining treatment efficacy in patients with refractory functional dyspepsia: a randomized controlled trial

HIGHLIGHTS

• who: Qian-Qian Wang from the University of Tu00fcbingen, Germany have published the research work: Short-course antidepressant therapy reduces discontinuation syndrome while maintaining treatment efficacy in patients with refractory functional dyspepsia: A randomized controlled trial, in the Journal: (JOURNAL)
• what: The study aimed to provide practical advice on the prevention of ADS in patients with rFD receiving neuromodulator treatment. disorders; (ii) pregnancy or lactation; (iii) difficulty completing follow up or various factors affecting compliance; or (iv) a history of allergic reaction to any of the drugs used in the study. In this study, 269 . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.